← Search & browse all drugs
CARDIOVASCULAR SYSTEM › LIPID MODIFYING AGENTS › LIPID MODIFYING AGENTS, PLAIN › Other lipid modifying agents
dextrothyroxine
C10AX01
Forms & Strengths
- Oral tablets: 1 mg, 2 mg, 4 mg (historical/withdrawn in many markets)
Adult Dosing
- Initial dose: 1 to 2 mg orally once daily
- Maintenance dose: 4 to 8 mg orally once daily, adjusted based on serum cholesterol response
- Maximum daily dose: 8 mg daily
Pediatric Dosing
- Safety and efficacy not established in pediatric patients; generally not recommended
Indications
- Adjunctive therapy for reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (historical use)
Mechanism of Action
- Dextrorotatory isomer of thyroxine that stimulates the liver to catabolize and excrete cholesterol into the bile
- Exhibits lower metabolic and calorigenic activity compared to levothyroxine, though retaining some thyroid hormone receptor agonism
Contraindications
- Known hypersensitivity to dextrothyroxine or thyroid analogues
- Euthyroid patients with history of myocardial infarction or angina pectoris
- Organic heart disease
- Hypertension (severe)
- Advanced hepatic or renal impairment
- Pregnancy and lactation
Adverse Reactions
- Increased frequency and severity of anginal pain
- Myocardial infarction
- Cardiac arrhythmias
- Palpitations
- Insomnia
- Nervousness
- Weight loss
- Diarrhea
- Gastrointestinal distress
- Visual disturbances
Drug Interactions
- Anticoagulants (warfarin): potentiates hypoprothrombinemic effect, increasing bleeding risk
- Digitalis glycosides: increased risk of cardiac arrhythmias
- Sympathomimetics and other cardiotoxic agents: additive cardiovascular stimulation
- Oral hypoglycemics/insulin: may alter diabetic control due to metabolic effects
Curated Content: Needs Vetting Before Put to Clinical Use